InsiderClue
Insiders · Profile

Agger Mette Kirstine

Director at Enliven Therapeutics · Director at Trevi Therapeutics. Filing since 9 May 2019. CIK 0001722234

ELVN Enliven Therapeutics, Inc. Director · 1 trade TRVI Trevi Therapeutics, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ELVN Enliven Therapeutics, Inc.
16 Mar 2020
Director
Bought
187,500
$3.00M
15.1%
TRVI Trevi Therapeutics, Inc.
9 May 2019
Director
Bought
375,000
$3.75M
48.3%
2 decisions on file.